For example, KCL566 (IC-NST) harboured a stop-gain CDH1 mutation plus CDH1 LOH in CSF cfDNA, with neither aberration being detected in the matched plasma, primary tumour or metastatic lymph node samples. Here, CDH1 is linked to neoplasm.